Who owns Intra Cellular Therapies?
- Ticker: ITCI
- CUSIP Number: 46116x101
Tip: Access positions for across all investors
Analyze quarterly positions in Intra Cellular Therapies with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Intra Cellular Therapies stock
Who bought or sold Intra Cellular Therapies this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Huntington National Bank | 1.00 | $2.5k | 0% | Sep 2025 |
|
Who sold out of Intra Cellular Therapies?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Goldman Sachs Group | Mar 2025 | 1.5M | $194M |
| Jpmorgan Chase & Co | Mar 2025 | 760k | $100M |
| Henderson Group | Mar 2025 | 133k | $18M |
| DekaBank Deutsche Girozentrale | Jun 2025 | 52k | $4.1M |
| Bluefin Capital Management | Mar 2025 | 10k | $1.3M |
| KBC Group NV | Mar 2025 | 4.1k | $540k |
| Advisor Group Holdings | Jun 2025 | 797.00 | $60k |
| FTB Advisors | Mar 2025 | 148.00 | $20k |
| Kestra Investment Management | Jun 2025 | 44.00 | $5.8k |
| MV Capital Management | Mar 2025 | 2.00 | $264.000000 |